-
Products are supplied strictly for laboratory and scientific research — not for human or veterinary use.
Searches for “CJC-1295 with DAC vs without DAC” often treat the two names as simple versions of one product. For laboratory planning, the more important question is what molecular modification is present and how that affects the experimental design.
This comparison is for scientific research only. It does not provide dosing, administration, performance, anti-aging or treatment guidance.
DAC means Drug Affinity Complex. In CJC-1295 research, the modification is associated with binding to albumin, which changes persistence compared with shorter-acting growth-hormone-releasing-hormone analogues.
Researchers should verify the exact sequence and modification stated for the material. Commercial naming is not always used consistently, and “without DAC” is sometimes discussed alongside modified GRF 1-29 terminology.
A longer-persisting analogue and a shorter-persisting analogue can produce different exposure profiles in an experimental model. This affects sampling intervals, washout design, control selection and how results are interpreted.
Neither profile is universally “better.” The appropriate material depends on whether the protocol is investigating sustained receptor engagement, shorter signaling patterns, comparative pharmacology or another defined endpoint.
| Research consideration | With DAC | Without DAC / shorter analogue |
|---|---|---|
| Structural distinction | Includes affinity-complex modification | Does not include DAC |
| Albumin interaction | Designed to increase albumin association | Lacks the DAC-mediated association |
| Exposure pattern | Longer persistence is commonly investigated | Shorter persistence is commonly investigated |
| Protocol impact | Longer observation and washout may be relevant | Denser early sampling may be relevant |
| Selection basis | Study objective and documented identity | Study objective and documented identity |
Differences in molecular persistence do not establish that a research product is safe, approved or effective for human use. FDA enforcement has specifically shown that “research use only” wording does not protect a seller whose surrounding content markets products for human effects.
Naming can vary. Confirm the documented sequence and modification rather than relying only on a storefront title.
No. It changes the experimental question and study design.
Browse GenLab Meds growth-hormone research peptides and verify the details on each product page.
Sources: Published CJC-1295 pharmacokinetic study record; FDA warning letter on research-use marketing
